Are you 18 years or older and living with moderately to severely active Ulcerative Colitis (UC)? If you have not responded adequately to previous treatment, you may be eligible to join our Phase II clinical research study.

The study includes a 10-week induction period, followed by a 40-week active treatment period and an approximately 1-year long-term extension.

If you are interested in participating and want to learn more about eligibility, please contact our research team today.